CyteGen

Wauwatosa, United States

CyteGen discovers new pathways that impact mitochondrial fitness and demonstrated recovery of cardiovascular and neurological function.

$1.1M raised

Jan 2022

Venture - Series Unknown

Top Investors

30,000+ verified contacts

Emails, phones & LinkedIn profiles

How much funding has CyteGen raised?

CyteGen has raised $1.1M in total funding. The most recent round was Venture - Series Unknown. The last funding was announced in January 2022.

Who are CyteGen's investors?

CyteGen's investors include Breakout Labs.

Where is CyteGen headquartered?

CyteGen is headquartered in Wauwatosa, United States.

What does CyteGen do?

CyteGen discovers new pathways that impact mitochondrial fitness and demonstrated recovery of cardiovascular and neurological function.

What stage is CyteGen at?

CyteGen is at the Venture - Series Unknown stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated January 10, 2022.

MLA

"CyteGen — Funding & Investors." VCBacked, January 10, 2022, https://www.vcbacked.co/company/cytegen. Accessed July 2, 2026.

APA

VCBacked. (2022). CyteGen — Funding & Investors. Retrieved July 2, 2026, from https://www.vcbacked.co/company/cytegen

Wikipedia (cite web)

{{cite web |title=CyteGen — Funding & Investors |url=https://www.vcbacked.co/company/cytegen |website=VCBacked |access-date=July 2, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated January 10, 2022.